- Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients
-
Shin HP, Burman B, Kozarek RA, Zeigler A, Wang C, Lee H, Zehr T, Edwards AM, Siddique A
- KMID: 2389360
- Gut Liver.
- 2017 Sep;11(5):711-720.
- doi: 10.5009/gnl16447
BACKGROUND/AIMS: The approval of sofosbuvir (SOF), a direct-acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). METHODS: We assessed the sustained virological response (SVR) of SOF-based regimens in... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
-
Shin HP, Park JA, Burman B, Kozarek RA, Siddique A
- KMID: 2406040
- Clin Mol Hepatol.
- 2017 Dec;23(4):316-322.
- doi: 10.3350/cmh.2016.0087
BACKGROUND/AIMS: Treatment of chronic hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD) is essential. The availability of sofosbuvir (SOF) has dramatically improved overall HCV cure rates,... -
- CITED
-
- Close
- SHARE
-
- Close
